Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.38 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1081317 | 1.00 | OPRM1 (0.43) | OPRM1LMNADNM1TSHRTHRB | |
| Hexane SCHEMBL1080155 | 1.00 | OPRM1 (0.43) | OPRM1LMNADNM1TSHRTHRB | |
| Hexane SCHEMBL244151 | 1.00 | OPRM1 (0.43) | OPRM1LMNADNM1TSHRTHRB | |
| Heptane SCHEMBL1323676 | 0.97 | TSHR (0.44) | OPRM1LMNADNM1TSHRTHRB | |
| Pentane SCHEMBL8736679 | 0.88 | TSHR (0.41) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL11395349 | 0.78 | TSHR (0.32) | TSHR | |
| SCHEMBL4447269 | 0.75 | OPRM1 (0.48) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL169284 | 0.75 | — | — | |
| SCHEMBL5999707 | 0.74 | TSHR (0.44) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL27908062 | 0.74 | TSHR (0.44) | OPRM1LMNADNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| EP-4105222-A1 | IRIDIUM COMPLEX COMPOUND, IRIDIUM COMPLEX COMPOUND-CONTAINING COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND PRODUCTION METHOD THEREFOR, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING DEVICE | Mitsubishi Chemical Corporation (JP) | 2022-12-21 | — | — | EP | disclosed |
| CN-115135662-A | Iridium complex compound, composition containing iridium complex compound, organic electroluminescent element and method for producing same, organic EL display device, and organic EL lighting device | 三菱化学株式会社 | 2022-09-30 | — | — | CN | disclosed |
| US-20180305283-A1 | Process for Preparing 2,6-Substituted Phenols | PPP CHEMISTRY B.V. (NL) | 2018-10-25 | — | — | US | disclosed |
| EP-3374339-A1 | PROCESS FOR PREPARING 2,6-SUBSTITUTED PHENOLS | PPP Chemistry B.V. (NL) | 2018-09-19 | — | — | EP | disclosed |
| WO-2017081133-A1 | PROCESS FOR PREPARING 2,6-SUBSTITUTED PHENOLS | PPP CHEMISTRY B.V. (NL) | 2017-05-18 | — | — | WO | disclosed |
| US-8546392-B2 | 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases | UNIVERSITAET DES SAARLANDES (DE) | 2013-10-01 | — | — | US | disclosed |
| EP-2418191-A1 | Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same | Meiji Co., Ltd. (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-7893304-B2 | Hydroquinone long-chain derivatives and/or phenoxy long-chain derivatives, and pharmaceuticals comprising the same | MEIJI DAIRIES CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-20100204234-A1 | 17Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Hormone-Related Diseases | UNIVERSITAET DES SAARLANDES (DE) | 2010-08-12 | — | — | US | disclosed |
| US-20090036542-A1 | Hydroquinone Long-Chain Derivative and/or Phenoxy Long-Chain Derivative and Pharmaceutical Comprising Same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2009-02-05 | — | — | US | disclosed |
| EP-1854777-A1 | HYDROQUINONE LONG-CHAIN DERIVATIVE AND/OR PHENOXY LONG-CHAIN DERIVATIVE, AND PHARMACEUTICAL PREPARATION COMPRISING THE SAME | Meiji Dairies Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036542-A1 | Hydroquinone Long-Chain Derivative and/or Phenoxy Long-Chain Derivative and Pharmaceutical Comprising Same | NQO1, NDUFA10, UQCRC1 | OPRM1 136/4885LMNA 2289/4885DNM1 2490/4885 |
| US-20100204234-A1 | 17Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Hormone-Related Diseases | HSD17B1, HSD17B11, HSD17B2 | OPRM1 4504/4885LMNA 3559/4885DNM1 1481/4885 |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | INF2, EMC2, DRD4 | OPRM1 563/4885LMNA 4621/4885DNM1 2599/4885 |
| US-20180305283-A1 | Process for Preparing 2,6-Substituted Phenols | DDT, EPHA6, CYP2B6 | OPRM1 251/4885LMNA 3290/4885DNM1 2216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.